GENOMIC HEALTH INC Camber Capital Management LP holding in Form 13-F
GHDX
Camber Capital Management LP reported holding of GHDX
Camber Capital Management LP reported holding of GHDX
This chart displays the historical ownership data of GHDX by Camber Capital Management LP. At the end of Q1 2014 the holding was valued at $19,755,000.
| Date | Holding Value |
|---|---|
| 19755000 | |
| 47265000 | |
| 56620000 | |
| 68736000 | |
| 64155000 | |
| 58359000 | |
| 51842000 | |
| 86525000 | |
| 60887000 | |
| 63652000 | |
| 71088000 | |
| 72244000 | |
| 77406000 | |
| 80011000 | |
| 78880000 | |
| 84067000 | |
| 76914000 | |
| 123888000 | |
| 0 |
Camber Capital Management LP reported holdings of GHDX from Q1 2014 to Q3 2018
Historical holdings data showing quarterly positions, market values, shares held, and portfolio percentages for GHDX held by Camber Capital Management LP from Q1 2014 to Q3 2018
FilingExplorer.com
https://creativecommons.org/licenses/by/4.0/
| Reporting period | Holding Type | Market Value | % of portfolio | Shares | Change in shares | % Change in shares | Qtr end price |
|---|---|---|---|---|---|---|---|
| Q1 2014 | Stock | $19,755,000 | 1.55% | 750,000 | 750,000 | 0 | $26.34 |
| Q2 2014 | Stock | $47,265,000 | 3.1% | 1,725,000 | 975,000 | 130.0% | $27.40 |
| Q3 2014 | Stock | $56,620,000 | 5.32% | 2,000,000 | 275,000 | 15.94% | $28.31 |
| Q4 2014 | Stock | $68,736,000 | 4.57% | 2,150,000 | 150,000 | 7.5% | $31.97 |
| Q1 2015 | Stock | $64,155,000 | 4.58% | 2,100,000 | -50,000 | -2.33% | $30.55 |
| Q2 2015 | Stock | $58,359,000 | 3.97% | 2,100,000 | 0 | 0 | $27.79 |
| Q3 2015 | Stock | $51,842,000 | 4.44% | 2,450,000 | 350,000 | 16.67% | $21.16 |
| Q4 2015 | Stock | $86,525,000 | 5.59% | 2,458,100 | 8,100 | 0.33% | $35.20 |
| Q1 2016 | Stock | $60,887,000 | 3.57% | 2,458,100 | 0 | 0 | $24.77 |
| Q2 2016 | Stock | $63,652,000 | 3.08% | 2,458,100 | 0 | 0 | $25.89 |
| Q3 2016 | Stock | $71,088,000 | 3.13% | 2,458,100 | 0 | 0 | $28.92 |
| Q4 2016 | Stock | $72,244,000 | 3.76% | 2,458,100 | 0 | 0 | $29.39 |
| Q1 2017 | Stock | $77,406,000 | 3.14% | 2,458,100 | 0 | 0 | $31.49 |
| Q2 2017 | Stock | $80,011,000 | 3.9% | 2,458,100 | 0 | 0 | $32.55 |
| Q3 2017 | Stock | $78,880,000 | 5.0% | 2,458,100 | 0 | 0 | $32.09 |
| Q4 2017 | Stock | $84,067,000 | 4.11% | 2,458,100 | 0 | 0 | $34.20 |
| Q1 2018 | Stock | $76,914,000 | 3.78% | 2,458,100 | 0 | 0 | $31.29 |
| Q2 2018 | Stock | $123,888,000 | 4.77% | 2,458,100 | 0 | 0 | $50.40 |
| Q3 2018 | Stock | $0 | 0 | 0 | -2,458,100 | -100.0% | - |